107 related articles for article (PubMed ID: 28881727)
21. TET proteins and the control of cytosine demethylation in cancer.
Scourzic L; Mouly E; Bernard OA
Genome Med; 2015; 7(1):9. PubMed ID: 25632305
[TBL] [Abstract][Full Text] [Related]
22. Detection of human T-lymphotropic virus type-I DNA and mRNA in the lymph nodes; using polymerase chain reaction in situ hybridization (PCR/ISH) and reverse transcription (RT-PCR/ISH).
Ohshima K; Suzumiya J; Izumo S; Mukai Y; Tashiro K; Kikuchi M
Int J Cancer; 1996 Mar; 66(1):18-23. PubMed ID: 8608960
[TBL] [Abstract][Full Text] [Related]
23. FoxP3+ regulatory T cells are distinct from leukemia cells in HTLV-1-associated adult T-cell leukemia.
Toulza F; Nosaka K; Takiguchi M; Pagliuca T; Mitsuya H; Tanaka Y; Taylor GP; Bangham CR
Int J Cancer; 2009 Nov; 125(10):2375-82. PubMed ID: 19544530
[TBL] [Abstract][Full Text] [Related]
24. Human T-lymphotropic virus 1 (HTLV-1)-associated lichenoid dermatitis induced by CD8+ T cells in HTLV-1 carrier, HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia/lymphoma.
Tokura Y; Ito T; Kawakami C; Sugita K; Kasuya A; Tatsuno K; Sawada Y; Nakamura M; Shimauchi T
J Dermatol; 2015 Oct; 42(10):967-74. PubMed ID: 26077665
[TBL] [Abstract][Full Text] [Related]
25. High Expression of Intestinal Homing Receptor CD103 in Adult T-Cell Leukemia/Lymphoma, Similar to 2 Other CD8+ T-Cell Lymphomas.
Ishibashi H; Nimura S; Ishitsuka K; Mihashi Y; Mizoguchi M; Nakamura S; Okamura S; Momosaki S; Aoyagi K; Sakisaka S; Takeshita M
Am J Surg Pathol; 2016 Apr; 40(4):462-70. PubMed ID: 26813744
[TBL] [Abstract][Full Text] [Related]
26. New entity, definition and diagnostic criteria of cutaneous adult T-cell leukemia/lymphoma: human T-lymphotropic virus type 1 proviral DNA load can distinguish between cutaneous and smoldering types.
Amano M; Kurokawa M; Ogata K; Itoh H; Kataoka H; Setoyama M
J Dermatol; 2008 May; 35(5):270-5. PubMed ID: 18477226
[TBL] [Abstract][Full Text] [Related]
27. Experimental acute adult T cell leukemia-lymphoma is associated with thymic atrophy in human T cell leukemia virus type I infection.
Simpson RM; Zhao TM; Hubbard BS; Sawasdikosol S; Kindt TJ
Lab Invest; 1996 Mar; 74(3):696-710. PubMed ID: 8600320
[TBL] [Abstract][Full Text] [Related]
28. Alteration of enhancer of polycomb 1 at 10p11.2 is one of the genetic events leading to development of adult T-cell leukemia/lymphoma.
Nakahata S; Saito Y; Hamasaki M; Hidaka T; Arai Y; Taki T; Taniwaki M; Morishita K
Genes Chromosomes Cancer; 2009 Sep; 48(9):768-76. PubMed ID: 19484761
[TBL] [Abstract][Full Text] [Related]
29. CCR4 frameshift mutation identifies a distinct group of adult T cell leukaemia/lymphoma with poor prognosis.
Yoshida N; Miyoshi H; Kato T; Sakata-Yanagimoto M; Niino D; Taniguchi H; Moriuchi Y; Miyahara M; Kurita D; Sasaki Y; Shimono J; Kawamoto K; Utsunomiya A; Imaizumi Y; Seto M; Ohshima K
J Pathol; 2016 Apr; 238(5):621-6. PubMed ID: 26847489
[TBL] [Abstract][Full Text] [Related]
30. Decreased TET2/5-hmC reduces the integrity of the epidermal barrier via epigenetic dysregulation of filaggrin in psoriatic lesions.
Zhang H; Jia T; Che D; Peng B; Chu Z; Song X; Zeng W; Geng S
J Dermatol Sci; 2024 Mar; 113(3):103-112. PubMed ID: 38331641
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic dysregulation of
García MG; Carella A; Urdinguio RG; Bayón GF; Lopez V; Tejedor JR; Sierra MI; García-Toraño E; Santamarina P; Perez RF; Mangas C; Astudillo A; Corte-Torres MD; Sáenz-de-Santa-María I; Chiara MD; Fernández AF; Fraga MF
Oncotarget; 2018 May; 9(40):25922-25934. PubMed ID: 29899831
[TBL] [Abstract][Full Text] [Related]
32.
Hiraide T; Suzuki H; Shinya Y; Momoi M; Inami T; Katsumata Y; Fukuda K; Kosaki K; Kataoka M
CJC Open; 2022 Apr; 4(4):416-419. PubMed ID: 35495859
[TBL] [Abstract][Full Text] [Related]
33. Leukaemia and lymphoma: The expansive reach of TET2.
Alderton GK
Nat Rev Cancer; 2011 Jul; 11(8):535. PubMed ID: 21779006
[No Abstract] [Full Text] [Related]
34. Loss of neuronal Tet2 enhances hippocampal-dependent cognitive function.
Pratt KJB; Shea JM; Remesal-Gomez L; Bieri G; Smith LK; Couthouis J; Chen CP; Roy IJ; Gontier G; Villeda SA
Cell Rep; 2023 Feb; 42(2):111926. PubMed ID: 36719799
[No Abstract] [Full Text] [Related]
35. TET2, an "ambiguous" player in inflammation.
Espinosa-Oliva AM; Burguillos MA
Neural Regen Res; 2020 Aug; 15(8):1481-1482. PubMed ID: 31997811
[No Abstract] [Full Text] [Related]
36. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers.
Li W; Zhang X; Lu X; You L; Song Y; Luo Z; Zhang J; Nie J; Zheng W; Xu D; Wang Y; Dong Y; Yu S; Hong J; Shi J; Hao H; Luo F; Hua L; Wang P; Qian X; Yuan F; Wei L; Cui M; Zhang T; Liao Q; Dai M; Liu Z; Chen G; Meckel K; Adhikari S; Jia G; Bissonnette MB; Zhang X; Zhao Y; Zhang W; He C; Liu J
Cell Res; 2017 Oct; 27(10):1243-1257. PubMed ID: 28925386
[TBL] [Abstract][Full Text] [Related]
37. Tet-mediated DNA hydroxymethylation regulates retinal neurogenesis by modulating cell-extrinsic signaling pathways.
Seritrakul P; Gross JM
PLoS Genet; 2017 Sep; 13(9):e1006987. PubMed ID: 28926578
[TBL] [Abstract][Full Text] [Related]
38. Prostate cancer diagnosis using epigenetic biomarkers, 3D high-content imaging and probabilistic cell-by-cell classifiers.
Stefanovski D; Tang G; Wawrowsky K; Boston RC; Lambrecht N; Tajbakhsh J
Oncotarget; 2017 Aug; 8(34):57278-57301. PubMed ID: 28915670
[TBL] [Abstract][Full Text] [Related]
39. TET proteins in natural and induced differentiation.
Scott-Browne JP; Lio CJ; Rao A
Curr Opin Genet Dev; 2017 Oct; 46():202-208. PubMed ID: 28888139
[TBL] [Abstract][Full Text] [Related]
40. Biological insights into the role of TET2 in T cell lymphomas.
Carty SA
Front Oncol; 2023; 13():1199108. PubMed ID: 37841428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
